Concepedia

S. B. Zimmerman

SB

Statistics

Publications

12

Citations

668

H-Index

12

Active since

1970

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

MSD K.K. (Japan)

S. B. Zimmerman is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and clinical microbiology.

Top concepts

PharmacologyMedicinePhysiologyAntibioticsBiochemistryBiosynthesisMicrobiologyPharmacotherapyChemical BiologyNatural Sciences

Publications per year

1970–1987

12

Publications

12

Cephamycins, a New Family of β-Lactam Antibiotics I. Production by Actinomycetes, Including <i>Streptomyces lactamdurans</i> sp. n

E. O. Stapley, M. Jackson, Sebastian Hernandez et al. · Antimicrobial Agents and Chemotherapy · 1972 · 177 citations · Full text

Cefoxitin, a Semisynthetic Cephamycin Antibiotic: Resistance to Beta-Lactamase Inactivation

Hiroshi Ōnishi, Donald R. Daoust, S. B. Zimmerman et al. · Antimicrobial Agents and Chemotherapy · 1974 · 154 citations · Full text

Difficidin and oxydifficidin: Novel broad spectrum antibacterial antibiotics produced by Bacillus subtilis. I.Production, taxonomy and antibacterial activity.

S. B. Zimmerman, Cheryl D. Schwartz, Richard L. Monaghan et al. · The Journal of Antibiotics · 1987 · 120 citations · Full text

Epithienamycins-novel .BETA.-lactams related to thienamycin I. Production and antibacterial activity.

E. O. Stapley, Patrick J. Cassidy, Josefino B. Tunac et al. · The Journal of Antibiotics · 1981 · 45 citations · Full text

Factumycin, a new antibiotic A40A: fermentation, isolation and antibacterial spectrum.

Vincent P. Gullo, S. B. Zimmerman, Ray S. Dewey et al. · The Journal of Antibiotics · 1982 · 34 citations · Full text

Rows per page

1–5 of 12